Concepedia

Akira Asagarasu

AA

Statistics

Publications

3

Citations

72

H-Index

3

Active since

2007

Affiliations

ASKA Pharmaceutical (Japan)(Current)

Akira Asagarasu is an author at ASKA Pharmaceutical (Japan) specializing in medicinal chemistry, drug discovery, and pharmacotherapy.

Top concepts

Publications per year

2007–2010

3

Publications

3

Discovery of a Novel 5-HT<sub>3</sub> Antagonist/5-HT<sub>1A</sub> Agonist 3-Amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3<i>H</i>)-one (TZB-30878) as an Orally Bioavailable Agent for Irritable Bowel Syndrome

Akira Asagarasu, Teruaki Matsui, Hiroyuki Hayashi et al. · Journal of Medicinal Chemistry · 2010 · 24 citations · Full text

, , +13

Design and Synthesis of Piperazinylpyridine Derivatives as Novel 5-HT1A Agonists/5-HT3 Antagonists for the Treatment of Irritable Bowel Syndrome (IBS)

Akira Asagarasu, Teruaki Matsui, Hiroyuki Hayashi et al. · Chemical and Pharmaceutical Bulletin · 2009 · 24 citations · Full text

, , +11

Pharmacological Properties of 3-Amino-5,6,7,8-tetrahydro-2-{4-[4-(quinolin-2-yl)piperazin-1-yl]butyl}quinazolin-4(3 H)-one (TZB-30878), a Novel Therapeutic Agent for Diarrhea-Predominant Irritable Bowel Syndrome (IBS) and Its Effects on an Experimental IBS Model

Satoru Tamaoki, Yukinao Yamauchi, Youichi Nakano et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 24 citations

1–3 of 3